tirzepatide dangers (Zepbound) for weight loss What are the known dangers

Over the past decade, studies have shown GLP-1 receptor agonists like semaglutide (Ozempic or Wegovy) reduce food seeking, but also alcohol intake, cocaine reward, nicotine self-administration, and relapse-like behavior spanning multiple drug classes

Overall, it's a great supplement that delivers on its promises

Read more Osteoporosis: Symptoms, Causes, DEXA Screening, and Treatment What Your Doctor Wants You to Know in 2026 Osteoporosis quietly weakens bones for years without a single symptom and nearly 1 in 2 women over 50 will break a bone because of it

In a randomized controlled trial involving obese individuals, tesofensine treatment led to significant reductions in body weight and improved metabolic parameters compared to placebo

Roughly 40% of participants taking semaglutide reported no heavy drinking days during the final month of the trial, compared to just 20% on placebo

This increased risk has led researchers and regulators to urge caution for patients with existing eye disease